Evidence map›Paper›PMID 29721026›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2017

Association of Ozone with 5-Fluorouracil and Cisplatin in Regulation of Human Colon Cancer Cell Viability: In Vitro Anti-Inflammatory Properties of Ozone in Colon Cancer Cells Exposed to Lipopolysaccharides.

Vincenzo Simonetti, Vincenzo Quagliariello, Pierangela Giustetto, Marianno Franzini, Rosario Vincenzo Iaffaioli

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Systemic Review: Ozone: A Potential New Chemotherapy.International journal of molecular sciences · 2021
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Complementary and Alternative Therapies in Oncology.International journal of environmental research and public health · 2022
    Review
  8. Article
  9. Article
  10. Application of ozone therapy in interventional medicine.Journal of interventional medicine · 2019
    Article
  11. Article
  12. Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?Evidence-based complementary and alternative medicine : eCAM · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vincenzo Simonetti"Kaos" ONLUS Foundation, Turin, Italy.ORCID 0000-0003-0548-6719
Vincenzo QuagliarielloOncology Department, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.
Pierangela GiustettoFreedom Waves Srl, Via Sicilia 31, 42122 Reggio Emilia, Italy.
Marianno FranziniOxygen-Ozone Therapy Scientific Society (SIOOT), Gorle, Italy.
Rosario Vincenzo IaffaioliOncology Department, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITInternational Flame Research Foundation · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOzone therapy is an effective medical treatment for different diseases like mucositis, psoriasis, acute pain, neurovascular diseases, and cancer. The aim of this study is based on the association of different ozone concentration with 5-fluorouracil and cisplatin in human colon cancer cell (HT29 cell line) in order to investigate possible anticancer synergistic effects.

methodsHT29 cells were incubated with ozone at different concentration ranging from 10 up to 50

resultsOzone alone has a time and concentration dependent cytotoxicity against HT29 cells (IC50 at 24 h: 30

conclusionThese results indicated that ozone could be useful in colon cancer management in combination with 5-fluorouracil and cisplatin with significant inhibition of cytokines having a central role in colon cancer cell survival and chemoresistance.

Identifiers

PMID29721026
PMCPMC5868048
OpenAlexW2734193224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.